According to a source familiar with the plans, Pfizer and BioNTech are anticipated to seek authorization this week from the United States for a second Covie-19 vaccine booster for people aged 65 and older. If the Food and Drug Administration (FDA) grants authorization, the additional shot would go to a group of people who are … Continue reading “Pfizer is Seeking U.S. Authorization for a 2nd Covid Booster for People 65 and Older”
Tag: bioNtech
Biotech & Pharma
Pfizer Now Says Coronavirus Vaccine is 95% Effective and Has Passed Safety Checks
The race is on for a coronavirus vaccine to hit the market as cases continue…
November 19, 2020
Biotech & Pharma
Pfizer Shares Explode as Company’s COVID-19 Vaccine Proves 90% Effective
Shares of pharmaceutical giant Pfizer were soaring on Monday to a new 52-week high after…
November 10, 2020
Biotech & PharmaLuxury
The United States Will Pay This Much to Pfizer and BioNTech for its COVID-19 Vaccine
As coronavirus cases keep surging, the U.S. is prepared to pay a steep amount for…
July 23, 2020
Biotech & Pharma
Pfizer and BioNtech Are Granted FDA Fast Track Designation for SARS-COV-2 Vaccine Candidates
Pharmaceutical giant Pfizer Inc. and BionTech SE made an exciting joint announcement on Monday that…
July 13, 2020